WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Stock Ownership - Who owns Takeda Pharmaceutical Co?

Insider buying vs selling

Have Takeda Pharmaceutical Co Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TAK insiders and whales buy or sell their stock.

TAK Shareholders

What type of owners hold Takeda Pharmaceutical Co Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Capital Research Global Investors0.91%14,297,805$191.02MInstitution
Mondrian Investment Partners Ltd0.52%8,167,393$109.12MInstitution
Millennium Management LLC0.41%6,492,911$86.75MInstitution
Morgan Stanley0.31%4,847,535$64.76MInstitution
Goldman Sachs Group Inc0.27%4,302,562$57.48MInstitution
Renaissance Technologies LLC0.21%3,327,400$44.45MInstitution
Brandes Investment Partners LP0.17%2,651,265$35.42MInstitution
Macquarie Group Ltd0.16%2,445,942$32.68MInstitution
Fmr LLC0.14%2,178,390$29.10MInstitution
Arrowstreet Capital Limited Partnership0.12%1,908,221$25.49MInstitution

1 of 3

TAK vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TAK5.30%0.00%
HLN4.42%0.00%
ZTS92.81%5.62%Net SellingNet Selling
TEVA51.71%0.97%Net SellingNet Selling
NBIX69.67%30.33%Net SellingNet Selling

Takeda Pharmaceutical Co Stock Ownership FAQ

Who owns Takeda Pharmaceutical Co?

Takeda Pharmaceutical Co (NYSE: TAK) is owned by 5.30% institutional shareholders, 0.00% Takeda Pharmaceutical Co insiders, and 94.70% retail investors. Capital Research Global Investors is the largest individual Takeda Pharmaceutical Co shareholder, owning 14.30M shares representing 0.91% of the company. Capital Research Global Investors's Takeda Pharmaceutical Co shares are currently valued at $191.30M.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.